Year’s comments for 1999 by Ricardo Guerrero
205
In contrast with what you may see elsewhere, INTERNATIONAL
MICROBIOLOGY will not present you with discoveries and
breakthroughs of the millennium, not even those of the century,
in part because the century and millennium seem to end in
December 31, 2000. No matter that
scientists such as Stephen Jay Gould
have kept explaining why it is so, and
even the highest authority in Spain has
stated his agreement  with scientists,
celebrations of the turning of the
millennium have been scheduled
around the world for December 31,
1999. We will comment on events and
discoveries of only 1999. Among the
notable discoveries, one is entitled to
enter the book of records: a bacterium
that exceeds by up to 100-fold the
biovolume of the largest known
prokaryotes was described (Schulz et
al., Science 284:493–496). This huge
sulfur bacterium was found in large
populations in continental shelf sedi-
ments underlying the oxygen minimum
zone of the Benguela Current up-
welling system, off Namibia coast. The
name Thiomargarita [pearl of sulfur]
namibiensis is suggested for this
organism. Mariona Hernández Mariné,
from the School of Pharmacy of the
University of Barcelona is one of the
authors of the article. The mass media
have no paid much attention to this
finding, probably because the authors did not pretend that the
newly-discovered organism could have any application in the
cure of cancer.
As in previous years, because of their roles as gene vectors
in biotechnology, microorganisms have been involved indirectly
in public debates. Mass media have again devoted much time
and space to “inform” the public of genetically modified
organisms (GMOs); they talk about the potential dangers of the
uncontrolled spread of genes with a pessimistic envisage.
Environmentalists in most European countries have organized
campaigns against GMOs and, along with the media, have
influenced consumers to be reluctant to
genetically modified products. The
controversy aroused by topics such as
the release of GMOs and human
cloning make it obvious the need for
what has been called “public unders-
tanding of science.” According to the
Eurobarometer published by the
European Commission DG XII in 1997,
when asked whom they trusted most
about genetically engineered crops, only
6% of European citizens named
universities and 4% public authorities.
Some 26% trusted environmental
organizations the most. The media
released news  of a nosocomial “epide-
mics” in Spanish Public hospitals
caused by the fungus Aspergillus in late
January. Even though health authorities
made it clear that nosocomial infection
levels in Spanish hospitals were
similar—or even lower—to those in
other Western countries, and that there
was no reason for alarm, the lack of
confidence in such authorities lingered.
This example of the power of mass
media in the spread of information
reinforces the results of the European
Commission survey. Nevertheless, a survey carried out by the
Spanish Center for Sociologic Research in December 1998
revealed that 60% Spaniards believe that a cure for cancer will
be found in the next ten years, and that a vaccine against AIDS
will be achieved during the 21st Century.
The race for new total DNA sequences has increased its pace.
At the end of 1998 the first sequence of an animal, the nematode
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Cover of the April 16, 1999, issue of Science. The
photograph corresponds to the large sulfur bacterium
Thiomargarita, which was discovered in sediments
off the coast of Namibia. The image was taken by
Ferran Garcia-Pichel. One of the authors of the article
(Schulz et al. Science 284:493–495) is Mariona
Hernández Mariné. (Reprinted with permission.
Copyright 1999 American Association for the
Advancement of Science.)
Caenorhabditis elegans, was published; it showed that the so
called “higher” organisms do not differ radically from “lower”
ones, as thought. Until November 1999, the complete microbial
genomes published this year were those of Helicobacter pylori
(Alm et al., Nature 397:176–180), Chlamydia pneumoniae
(Kalman et al., Nature Genet 21:385–389), Aeropyrum pernix
(Kawarabayasi et al., DNA Research 6:83–101) and Thermotoga
maritima (Nelson et al., Nature 399:323–329). In the process
of sequencing two major human parasites, chromosome 2 of
Plasmodium falciparum and chromosome 1 of Leishmania major
were also published. In addition, the sequences of Campylobacter
jejuni, Deinococcus radiodurans and Pyrococcus abyssi were
also completed but are not yet published. According to the
Institute for Genomic Research (TIGR, www.tigr.org/tdb/
mdb/mdb.html), the sequences of Bacillus halodurans,
Bartonella henselae, Corynebacterium glutamicum, Entero-
coccus faecalis, Methanosarcina mazei, Mycobacterium
tuberculosis (strain CSU#93, clinical isolate), Mycoplasma
mycoides subsp. mycoides, Porphyromonas gingivalis,
Rhodobacter capsulatus, Streptococcus pneumoniae, Thermus
thermophilus, Ureaplasma urealyticum, and Vibrio cholerae are
expected to be completed soon.
Over the last decades, infectious diseases such as tuber-
culosis and some sexually transmissible diseases have
reemerged, whereas others, such as legionellosis and Lyme
disease have been described for the first time. Fortunately, other
diseases have disappeared. In 1980 the World Health
Organization (WHO) announced the eradication of smallpox.
Nevertheless, stocks of the variola virus, which causes the
disease, have been kept in cultures in the United States (at
the Centers for Disease Control and Prevention in Atlanta,
Georgia) and Russia (at Vector, Russia’s State Research Center
for Virology and Biotechnology, near Novosibirsk). The WHO
proposed those two remaining stocks be destroyed in 1966.
The US first backed that proposal whereas Russia has always
been against it. After a report from the Institute of Medicine
in Washington DC, President Clinton decided that the US would
also keep the virus stock. The decision of both countries was
made official at the World Health Assembly held in Geneva in
May this year. Among the reasons to justify not to destroy the
virus is the potential loss of scientific research and the potential
to develop treatments against other viruses such HIV. Those in
favor of destroying it alleged that it would be the only way to
prevent the reemergence of smallpox—provided that all
countries kill the virus.
A gleam of hope in the fight against tuberculosis has been
provided by the possible application of DNA vaccines. In
experiments carried out in mice, besides preventing infection
by Mycobacterium tuberculosis, DNA vaccines have proven
to be efficient therapeutic agents which stimulate the immune
system in infected individuals. Their combination with
conventional chemotherapeutic antibacterial drugs can speed
up the cure of the disease (Lowrie et al., Nature 400:269–271).
(The DNA Vaccine Web, www.genweb.com/Dnavax.html,
provides recent information on this kind of vaccines.) Another
step to prevent infectious diseases for which no vaccines are
yet available has been the discovery of a gene that controls the
activity of other genes needed for the infection by Salmonella
typhimurium. Bacteria in which the gene was eliminated no
longer infected their host, although they still caused a strong
immune response in mice (Douglas et al. Science 284:967–970).
The same team found other regulator genes, such as dam (DNA
adenine methylase), which is involved in DNA repair and in
the formation of pili. The absence of the gene altered the
expression of virulence. A new generation of antibiotics are
anticipated to result from the search for drugs that block Dam.
This issue of INTERNATIONAL MICROBIOLOGY completes the
second year of the renewed journal of the Spanish Society for
Microbiology (SEM). The goals that the SEM aimed in
relaunching the journal have been achieved: to produce an up-to-
date visually attractive publication that keeps pace with other
international journals. Our highest priority is to maintain an
excellent standard of published articles. Three monographic issues
have been published in this period (1998–1999): “Perspectives
in non-conventional fungi research” (vol. 1[2], June 1998), “Ten
years of CIBE-Merck Symposia” (vol. 1[4], December 1998) and
“Microbial pathogenesis” (vol. 2[3], September 1999). 
INTERNATIONAL MICROBIOLOGY publishes two kind of papers:
Articles (either research and review ones) and Complements
(editorials, perspectives and opinion). Through Perspectives
and Opinion papers we generate snapshots of microbiology’s
history in the biological context. Such papers, not usually found
on specialized scientific journals, have been welcomed by our
readers. A novelty in the journal has been publishing color
photographs. Unfortunately, our journal cannot afford the
expense of color and must request the authors themselves cover
it.
We have received 92 submissions of manuscripts in 1999.
The four issues of the year comprise 32 Articles and 14
Complements, with a total of 290 pages. Do you remember
that some people in Europe used special glasses to watch the
solar eclipse in August 11? Now you will need also special
glasses to see properly the 3D micrograph on the cover of
this issue of INTERNATIONAL MICROBIOLOGY. We make a call
to those of you who have good micrographs of viruses,
bacteria, protists or fungi (see the cover’s background of each
issue). Please send them as soon as possible for tentative
publication throughout 2000. The SEM is privileged to
produce a “young” 50-year old microbiology publication that
aims to be among the best in Europe. Please help us to
achieve this goal by sending us your best scientific
contributions and by asking your libraries and departments
to take out an institutional subscription.
Ricardo Guerrero
Editor-in-Chief
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